Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

Similar articles for PubMed (Select 24339259)

1.

Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.

Guo M, Khanna A, Dhillon J, Patel SJ, Feng J, Williams MD, Bell DM, Gong Y, Katz RL, Sturgis EM, Staerkel GA.

Cancer Cytopathol. 2014 Feb;122(2):96-103. doi: 10.1002/cncy.21375. Epub 2013 Dec 11.

PMID:
24339259
2.

Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.

Kerr DA, Pitman MB, Sweeney B, Arpin RN 3rd, Wilbur DC, Faquin WC.

Cancer Cytopathol. 2014 Mar;122(3):167-74. doi: 10.1002/cncy.21372. Epub 2013 Nov 20.

PMID:
24259368
3.

Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma.

Solomides CC, Bibbo M, Wang ZX.

Acta Cytol. 2012;56(2):196-8. doi: 10.1159/000335730. Epub 2012 Feb 17.

4.

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.

Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Nov;44(11):2385-92. doi: 10.1016/j.humpath.2013.07.011. Epub 2013 Sep 24.

PMID:
24071016
5.

Human papillomavirus (HPV) assays for testing fine-needle aspiration specimens in patients with head and neck squamous cell carcinoma.

Faquin WC.

Cancer Cytopathol. 2014 Feb;122(2):92-5. doi: 10.1002/cncy.21374. Epub 2013 Dec 11. No abstract available.

PMID:
24339237
8.

The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck.

Holmes BJ, Westra WH.

Diagn Cytopathol. 2014 Jan;42(1):85-93. doi: 10.1002/dc.23014. Epub 2013 Jun 8. Review.

PMID:
23749770
9.

Biomarkers of HPV in head and neck squamous cell carcinoma.

Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT.

Cancer Res. 2012 Oct 1;72(19):5004-13. doi: 10.1158/0008-5472.CAN-11-3277. Epub 2012 Sep 18.

10.

High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods.

Walline HM, Komarck C, McHugh JB, Byrd SA, Spector ME, Hauff SJ, Graham MP, Bellile E, Moyer JS, Prince ME, Wolf GT, Chepeha DB, Worden FP, Stenmark MH, Eisbruch A, Bradford CR, Carey TE.

JAMA Otolaryngol Head Neck Surg. 2013 Dec;139(12):1320-7. doi: 10.1001/jamaoto.2013.5460.

11.

Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin.

Baldassarri R, Aronberg R, Levi AW, Yarbrough WG, Kowalski D, Chhieng D.

Am J Clin Pathol. 2015 May;143(5):694-700. doi: 10.1309/AJCPCZA4PSZCFHQ4.

PMID:
25873503
12.

Detection of HPV infection in head and neck squamous cell carcinoma: a practical proposal.

Dreyer JH, Hauck F, Oliveira-Silva M, Barros MH, Niedobitek G.

Virchows Arch. 2013 Apr;462(4):381-9. doi: 10.1007/s00428-013-1393-5. Epub 2013 Mar 17.

PMID:
23503925
13.

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.

Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB.

Mod Pathol. 2011 Oct;24(10):1295-305. doi: 10.1038/modpathol.2011.91. Epub 2011 May 13.

14.
15.

The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas.

Jakscha J, Zlobec I, Storck C, Obermann EC, Tornillo L, Terracciano LM, Fischer CA.

Eur Arch Otorhinolaryngol. 2013 Feb;270(2):661-7. doi: 10.1007/s00405-012-2039-y. Epub 2012 May 16.

PMID:
22588195
16.

p16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma.

Grimes R, Garcia-Buitrago MT, Jorda M, Ganjei-Azar P, Ferrell A, Gomez-Fernandez C.

Acta Cytol. 2013;57(1):33-7. doi: 10.1159/000342501. Epub 2012 Dec 6.

PMID:
23221169
17.

P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.

Mooren JJ, Gültekin SE, Straetmans JM, Haesevoets A, Peutz-Kootstra CJ, Huebbers CU, Dienes HP, Wieland U, Ramaekers FC, Kremer B, Speel EJ, Klussmann JP.

Int J Cancer. 2014 May 1;134(9):2108-17. doi: 10.1002/ijc.28534. Epub 2013 Oct 21.

PMID:
24127203
18.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D.

J Natl Cancer Inst. 2000 May 3;92(9):709-20.

19.

Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.

Lin BM, Wang H, D'Souza G, Zhang Z, Fakhry C, Joseph AW, Drake VE, Sanguineti G, Westra WH, Pai SI.

Cancer. 2013 Oct 1;119(19):3462-71. doi: 10.1002/cncr.28250. Epub 2013 Jul 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk